Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $113.86M.
ENTERPRISE VALUE (EV)
$113.86M
Apyx Medical Corporation
Market Cap
$110.75M
Enterprise Value (EV)
$113.86M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Apyx Medical Corporation (APYX) | $110.75M | $113.86M |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.17M | $108.94M |
| Immunic, Inc. (IMUX)vs › | $109.93M | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.94M | $89.84M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $112.56M | $88.48M |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.58M | $108.43M |
| Coya Therapeutics, Inc. (COYA)vs › | $114.00M | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $115.55M | $42.38M |
| Genelux Corporation (GNLX)vs › | $116.59M | $109.82M |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | $92.45M |
Market Cap
$110.75M
Total Debt
$34.85M
Cash
$31.74M
Enterprise Value
$113.86M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
